Market Reversal Today -Be Cautious
The market reversed today about 1:30p EDT as positive Bernanke chat yielded to Trichet and the Baklava Bailout. The NASDAQ Comp was up to the 2430 range then closed at 2397. The Rayno Life Science Index of 34 mid-cap biotechs was up 1.7% with 32 greens at 1:30p then finished down 0.5% with...
2009-2010 Life Sciences Portfolio
The Raygent Model Portfolio was created in February 2009 and will be updated by the end of March 2010.The 14 month YTD performance is up 25%. New buys over past four months were Sequenom (SQNM) and SeraCare (SRLS). Currently under review are Immucor (BLUD) , MicroFluidics (MLFU) , Genomic...
Healthcare Stocks up-Market absorbs Reform
Healthcare and biotech stocks were up today as expected following passage of the historic reform bill. Although there is a considerable amount of work to be done in enabling the historic legislation, uncertainty has been removed and the market can play it out. Many analysts and economists...
2010 Life Science Portfolio-Look at Immucor (BLUD)
We are currently rebalancing our 2010 Life Science Portfolio (See under "Articles" at top of WEB site). We are updating our Diagnostics and Genomics Model Portfolio as follows: Our winners for a 14 month period YTD are Abaxis (ABAX),Hologic (HOLX), Illumina(ILMN) and Inverness(IMA). All remain...
Sequenom (SQNM) Catching Bids at $5.75
Sequenom is finding price support today at $5.75, volume of 4.6M at 1p, after a severe three day downdraft triggered by their earnings release. Net loss for Q4 was $18.4M on Revenues of $10.8M. Cash position is $42M. Some pundits didn't like the inability of the Company to give a detailed...